The second Science and Innovation Management Studies (SIMS) Executive Course, entitled "Intellectual property, licensing and pipeline for value creation", will take place in Barcelona from 22-24 March 2007. The course will bring together leading experts from American and European companies with up to 30 junior biotech managers.
The courses will consist of four modules covering the following themes: Basic Business Essentials of Biotechnology; IP, Licensing and the Pipeline for Value Creation; Biotech Financing, Partnering, M&As and Strategic alliances and Clinical Trial Strategy and Regulatory Approval.
The upcoming module will cover the basics of patent law, the development of a strong patent portfolio and the importance of industry versus patents. SIMS intends to teach students basic skills including how to build a pipeline for creative value, how to sell and buy IP and how to choose the right IP strategy as well as exposing participating scientists and companies to new research and business opportunities, giving them a better understanding of the technology markets and the technological value chains. The faculty of experts will include Mrs. Margaret Beer, Director and Scientific Liaison at Merck, Mrs. Nancy Levi, the President of Bio-Health Management in Boston, Mr. Jorn Roland Muller, partner at Vossius and Partner and Mrs. Denise Hirsch, Director of IP at INSERM in Paris. The Programme Director will be Mr. Jos Carlos Gutirrez-Ramos, Vice-President of R&D at San Francisco-based Avidia, and former Vice President for Inflammation at Millennium Pharmaceuticals.
The first module of the course, "Basic Business Essentials of Biotechnology", took place in Barcelona from 29 June -- 1 July 2006, bringing together 10 industry experts and 24 participants, over two thirds of whom stated that they would actively recommend the course. One of the attendees, Fouzia Laghrissi of the Roche Licensing department claimed that "It was a great pleasur
Contact: Fred Glaser